Latest Asx News

Nick Scali Limited reported a stronger-than-expected half-year profit, driven by solid ANZ performance, while its UK operations continue to face restructuring challenges amid store refurbishments.

Neuren Pharmaceuticals has secured a pivotal FDA Type C Meeting to discuss primary efficacy endpoints for its Phase 3 trial of NNZ-2591 targeting Phelan-McDermid syndrome, advancing its rare disease drug development.

Miramar Resources has confirmed the Bangemall region as a significant new nickel-copper province following detailed Micro-XRF analysis of drill samples from its Mount Vernon Project, revealing disseminated nickel and copper sulphides. This breakthrough positions Miramar as a first-mover with a dominant landholding in a highly prospective area.

Lightning Minerals has appointed Energold Drilling S.A. to commence a 2,000m diamond drilling program at its Esperança lithium project in Brazil, targeting spodumene-bearing pegmatites identified late last year.

Shekel Brainweigh Ltd has requested an immediate suspension from ASX quotation as it moves towards removal from the official ASX list, raising questions about the company’s future.

SEQ Hospitality Group has formally withdrawn its off-market takeover bid for Eumundi Group following shareholder and court approval of a competing scheme of arrangement. This move effectively ends the takeover offer and confirms the scheme as the path forward for Eumundi shareholders.

ReNu Energy has agreed to sell its Countrywide Hydrogen Business, including a key Tasmanian green hydrogen project, to a management-controlled entity for up to $1.1 million, pending shareholder approval. This strategic divestment aims to relieve financial pressures and reposition the company as a debt-free vehicle focused on new growth opportunities.

Orbminco Limited has defined significant new drill targets at its Bronze Fox Copper-Gold Project in Southern Mongolia, following promising trench sampling results and geophysical surveys. The company is gearing up for an expanded drilling campaign in mid-2025 to explore these high-potential zones.

SOCO Corporation Ltd has posted a preliminary 18% increase in first-half FY2025 revenue to $11 million, yet project delays and reduced federal government demand temper full-year growth expectations.

Polymetals Resources Ltd has temporarily paused trading of its securities, signaling an imminent announcement that could reshape investor expectations.

Actinogen Medical has published a peer-reviewed article confirming the efficacy of a 10 mg daily dose of Xanamem for treating neurological conditions, reinforcing its ongoing clinical trials in Alzheimer's and depression.

Northern Minerals has completed the second tranche of its placement, raising $41.5 million to advance its Browns Range Heavy Rare Earth Project, focusing on the high-grade Wolverine deposit.